Blog
RSS FeedPosted by Michael Wonder on 10 Sep 2025
Enhanced access to generalised myasthenia gravis treatments: UCB Canada secures pCPA agreements for Zilbrysq and Rystiggo
9 September 2025 - Important milestone brings eligible Canadians living with generalised myasthenia gravis one step closer to accessing innovative ...
Posted by Michael Wonder on 10 Sep 2025
Pfizer's Prevnar 20 selected for pneumococcal public immunisation program in British Columbia
9 September 2025 - Today, Pfizer Canada announced that its 20 valent pneumococcal conjugate vaccine, Prevnar 20, has been selected for ...
Posted by Michael Wonder on 09 Sep 2025
Reimbursement delay leaves Korean patients waiting for Padcev-Keytruda first-line therapy
8 September 2025 - The first-line combination therapy of Padcev and Keytruda for metastatic urothelial carcinoma was not even submitted ...
Posted by Michael Wonder on 03 Sep 2025
'More than my rent': NSW woman's $1000 a month fight for relief
3 September 2025 - Six years ago, Raphaella Kathryn Crosby could barely get out of bed. ...
Posted by Michael Wonder on 02 Sep 2025
Multiple myeloma drug Darzalex to get expanded coverage from September
29 August 2025 - Starting in September, reimbursement for the multiple myeloma treatment Darzalex (daratumumab) will be expanded, reducing the ...
Posted by Michael Wonder on 02 Sep 2025
New free vaccine to protect kids against pneumococcal
2 September 2025 - Australian children will now have stronger protection against pneumococcal with the Australian Government implementing a new ...
Posted by Michael Wonder on 01 Sep 2025
PHARMAC confirms continued access to Comirnaty COVID-19 vaccine
1 September 2025 - PHARMAC has secured a new supply agreement with Pfizer to continue funding the Comirnaty brand of ...
Posted by Michael Wonder on 01 Sep 2025
Care for people with rare and less common cancers ‘delayed and fragmented’, new report reveals
1 September 2025 - A national survey of nearly 2,500 people affected by cancer has found those with a rare ...
Posted by Michael Wonder on 01 Sep 2025
More cheaper medicines now available for Australians
1 September 2025 - From today, Australians with paediatric psoriasis, fibrodysplasia, asthma, cystic fibrosis and blood cancer now have access ...
Posted by Michael Wonder on 01 Sep 2025
Schedule of Pharmaceutical Benefits - 1 September 2025
1 September 2025 - The September 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 01 Sep 2025
New Zealand Pharmaceutical Schedule - 1 September 2025
1 September 2025 - The September 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 Aug 2025
Game changing asthma treatment for kids listed on PBS
29 August 2025 - A new antibody treatment for severe asthma in children is about to become significantly more affordable ...
Posted by Michael Wonder on 31 Aug 2025
Vabysmo (faricimab injection) now publicly funded for macular oedema secondary to retinal vein occlusion in Ontario
29 August 2025 - Roche Canada is pleased to announce today that Vabysmo (faricimab injection) is now publicly funded for ...
Posted by Michael Wonder on 25 Aug 2025
Committee rejects application for medication Keytruda to be subsidised for Aussies with cancer
23 August 2025 - Australians with rare cancers like Natalie Willacy have just been handed a devastating hit, which could leave ...
Posted by Michael Wonder on 24 Aug 2025
New Alzheimer’s drug rejected for PBS listing, leaving patients to pay up to $80k a year
23 August 2025 - New Alzheimer’s drug rejected for PBS listing, leaving patients to pay up to $80k/year. ...